BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).

Published in:

Clinical Infectious Diseases, 2022, v. 74, n. 7, p. 1268, doi. 10.1093/cid/ciab648

By:

• Woldemeskel, Bezawit A;
• Karaba, Andrew H;
• Garliss, Caroline C;
• Beck, Evan J;
• Wang, Kristy H;
• Laeyendecker, Oliver;
• Cox, Andrea L;
• Blankson, Joel N

Publication type:

Article